Drug Profile
Estradiol oral - Theramex SAM
Alternative Names: Estreva oral; TX 13323Latest Information Update: 19 Dec 2021
Price :
$50
*
At a glance
- Originator Theramex SAM
- Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Menopausal syndrome; Postmenopausal osteoporosis
Most Recent Events
- 01 Feb 2018 Teva Women's Health was sold by Teva Pharmaceuticals to CVC Capital Partners, to create an international pharmaceutical company dedicated to Women’s Health named Theramex
- 06 Jan 2011 Theramex SAM has been acquired by Teva Pharmaceutical Industries
- 20 Dec 1999 Theramex SAM acquired by Merck KGaA